EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PW Medtech Group's Enterprise Value is HK$-169.1 Mil.
PW Medtech Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$141.2 Mil. Therefore, PW Medtech Group's EV-to-FCF for today is -1.20.
The historical rank and industry rank for PW Medtech Group's EV-to-FCF or its related term are showing as below:
HKSE:01358'
s EV-to-FCF Range Over the Past 10 Years
Min: -490.86 Med: -44.39 Max: 69.81
Current: -1.52
During the past 12 years, the highest EV-to-FCF of PW Medtech Group was 69.81. The lowest was -490.86. And the median was -44.39.
HKSE:01358's EV-to-FCF is ranked better than 98.89% of 360
companies
in the Medical Devices & Instruments industry
Industry Median: 27.715
vs HKSE:01358: -1.52
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for PW Medtech Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PW Medtech Group's EV-to-FCF
For the Medical Instruments & Supplies subindustry, PW Medtech Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's EV-to-FCF falls into.
PW Medtech Group's current Enterprise Value is HK$-169.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$141.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (HKSE:01358) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
PW Medtech Group's PE Ratio for today is calculated as:
PW Medtech Group's share price for today is HK$1.09.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.107.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PW Medtech Group EV-to-FCF Related Terms
Thank you for viewing the detailed overview of PW Medtech Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
PW Medtech Group (HKSE:01358) Business Description
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01358 has been successfully added to your 